FB-TW

Showing posts with label coronary artery plaque. Show all posts
Showing posts with label coronary artery plaque. Show all posts

Thursday, October 18, 2012

Does Fish oil fail to deliver on its promise? Listen to an expert.

Fish Oil - Good for you or not?

Several articles in the news lately, pretty much said that taking fish oil, or omega 3's, did nothing to help prevent heart disease. Should you toss your supply? Hear what Dr. Blanchet has to say about omega 3’s and their role in our health. Find out the facts about the studies that were done which prompted the media concern.

Dr. Blanchet is my doctor and has helped me slow my coronary artery plaque to 5% per year. So do I take fish oil? You bet!

I am one of his patients over 65 years old and with a calcified plaque score of greater then 1000.

Listen to a pod cast by he and Lindsay talking about Omega-3 fatty acids here.
=================================================================
See other info about Dr. Blanchet here.

Sunday, October 14, 2012

Results of my second serial CAC Scan just in.

I have been working hard on slowing plaque growth for several years but mostly in the last year and a half because I had my first viable CAC scan to provide a measuring point baseline for reference.

Other comments on the report follow.
  • IMPRESSION: Stable exam compared to Sept 15, 2011

  • PATIENT: 69 year old man with no cardiac symptoms but a past history of cardiovascular disease resulting in 6 MI events over a 17 year period. His current stress level is low. He has a history of prior cardiac procedures including CABG (1x), Angiography and Coronary Stent (3x). He has a family history of stroke and heart disease in a first or second degree relative.

  • YOUR AGATSTON CALCIUM SCORE IS: 1072.3

  • Your current EBT heart was compared to your most recent prior scan and the progression of calcified plaque is less than 15% annually. This is a very good result and is consistent with a low risk for coronary event over the next few years.

Encouraging but no resting on my laurels. The 22% annualized plaque growth in the RCA is a matter of concern reminding me that further improvement is necessary so adjustments may have to be made in my diet etc.


Prior Scan was Sept 15, 2011
Current Scan Oct 5, 2012
My assessment is that it looks pretty good except for % change on LMCA and the RCA
That line below the chart that ends with 4% is good.
Have consult with doctor tomorrow (10/15/2012). Stay tuned for a more qualified analysis.




Note my treatment plan which seems to be paying off is that of the Track Your Plaque Program. It primarily consists of diet and supplements with minimal drug intervention (especially 'no statins' which I do not tolerate). It includes advanced lipid analysis then treating atherogenic ones such as Lp(a) and apo B or LDL particle number and particle size.

Friday, September 28, 2012

Statin use is associated with an increased prevalence and extent of coronary plaques possessing calcium


Statins use and coronary artery plaque composition: Results from the International Multicenter CONFIRM Registry.

Source

Cedars-Sinai Heart Institute and Department of Imaging, Cedars-Sinai Medical Center, Los Angeles, CA, USA. Electronic address: Ryo.Nakazato@cshs.org.

Abstract

OBJECTIVE:

The effect of statins on coronary artery plaque features beyond stenosis severity is not known. Coronary CT angiography (CCTA) is a novel non-invasive method that permits direct visualization of coronary atherosclerotic features, including plaque composition. We evaluated the association of statin use to coronary plaque composition type in patients without known coronary artery disease (CAD) undergoing CCTA.

METHODS:

From consecutive individuals, we identified 6673 individuals (2413 on statin therapy and 4260 not on statin therapy) with no known CAD and available statin use status. We studied the relationship between statin use and the presence and extent of specific plaque composition types, which was graded as non-calcified (NCP), mixed (MP), or calcified (CP) plaque.

RESULTS:

The mean age was 59 ± 11 (55% male). Compared to the individuals not taking statins, those taking statins had higher prevalence of risk factors and obstructive CAD. In multivariable analyses, statin use was associated with increased the presence of MP [odds ratio (OR) 1.46, 95% confidence interval (CI) 1.27-1.68), p < 0.001] and CP (OR 1.54, 95% CI 1.36-1.74, p < 0.001), but not NCP (OR 1.11, 95% CI 0.96-1.29, p = 0.1). Further, in multivariable analyses, statin use was associated with increasing numbers of coronary segments possessing MP (OR 1.52, 95% CI 1.34-1.73, p < 0.001) and CP (OR 1.52, 95% CI 1.36-1.70, p < 0.001), but not coronary segments with NCP (OR 1.09, 95% CI 0.94-1.25, p = 0.2).

CONCLUSION:

Statin use is associated with an increased prevalence and extent of coronary plaques possessing calcium. The longitudinal effect of statins on coronary plaque composition warrants further investigation.

Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.
PMID: 22981406 [PubMed - as supplied by publisher]
====================================================================
Read the complete article here.